StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
SILOSilo Pharma, Inc.
stockpulse.co.kr
Nasdaq
$1.20▲ 1.69%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $1.5MShares out 1.3M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

22
  • 10.14After-hours26.10.15 05:30
    8-KKey event#●●●#●●●

    Silo Pharma, Inc.

    On October 13, 2026, Silo Pharma, Inc. entered into an asset purchase agreement to acquire software and intellectual property related to 'Reputation Endpoints' from Larry King. The company issued 150,000 shares of common stock as consideration, which are subject to a 12-month lock-up period.…more

    $1.20+1.69%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 10.2After-hours26.10.03 05:37
    8-KKey event

    Silo Pharma, Inc.

    Silo Pharma has entered into an asset purchase agreement to acquire software and intellectual property from Norsight Consulting. In consideration, the company issued a warrant to purchase up to 300,000 shares of common stock with an exercise price of $1.51, subject to a 12-month lock-up period.…more

    $1.20+1.69%vs prev close
    View filingShare
  • 8.19After-hours26.08.20 06:17
    8-KKey event

    Silo Pharma, Inc.

    On August 18, 2026, Silo Pharma entered into an asset purchase agreement with Parkview Consulting LLC to acquire software, technology, and intellectual property. As consideration, the company issued 165,000 shares of its common stock, which are subject to a 12-month lock-up period.…more

    $1.20+1.69%vs prev close
    View filingShare

21 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 10.14After-hours26.10.15 05:35
    Bullish#●●●#●●●

    Silo Pharma to Acquire Software and IP from Larry King

    Silo Pharma has agreed to acquire software and related intellectual property from Larry King. The company will issue 150,000 shares as consideration for the acquisition.…more

    $1.20+1.69%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    ShareBenzinga
  • 10.2After-hours26.10.03 05:42

    ●●●●●●●● ●●●●● ●●●●●●

    Silo Pharma has entered into an agreement to purchase software and intellectual property assets from Norsight Consulting. The company issued warrants as consideration, which introduces potential share dilution for existing shareholders.…more

    $1.20+1.69%vs prev close
    ShareBenzinga
  • 9.30Pre-market26.09.30 21:50

    ●●●●●●●● ●●●●● ●●●●●●

    Silo Pharma's subsidiary QwikAgents has expanded its AI platform by adding support for NVIDIA models and new runtime flexibility. While this update enhances customer choice, there is no immediate financial impact or revenue guidance provided.…more

    $1.20+1.69%vs prev close
    Read sourceShareGlobeNewswire

2 more news items

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →